HealthEquity (HQY) Tops Q3 EPS by 4c, Beats on Revenues; Lowers FY18 EPS Mid-Point Guidance Below Consensus, FY18 Revenue Mid-Point Below Estimates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to HealthEquity (HQY) Tops Q3 EPS by 4c, Beats on Revenues; Lowers FY18 EPS Mid-Point Guidance Below Consensus, FY18 Revenue Mid-Point Below Estimates

HealthEquity, Inc (HQY) PT Lowered to $58 at Oppenheimer on 3Q Report; 'Lack of Legislative Tailwind Could Reset Valuation

December 6, 2017 8:30 AM EST

Oppenheimer lowered its price target on HealthEquity, Inc (NASDAQ: HQY) to $58.00 (from $61.00) while maintaining a Outperform rating, following the company's third quarter earnings report.

Analyst Mohan Naidu notes a cautious outlook due to "the lack of legislative tailwind in the recent tax bill... More